Artwork
iconShare
 
Manage episode 299097228 series 1923914
Content provided by DLA Piper TechLaw Podcast Series and DLA Piper. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by DLA Piper TechLaw Podcast Series and DLA Piper or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Podcast 41 of our TechLaw podcast series sees David Bell, Director at Hampleton Partners, leading M&A and corporate finance consultancy for companies with technology at their core, and DLA Piper Partner, Mark O’Conor, engage in an exciting conversation on the current innovations in HealthTech, as well as a futuristic outlook on the industry. Key highlights include the benefits of software as a medical device, macro factors influencing innovation and investment opportunities. Join David and Mark at our fifth European Technology Summit on the 5th October 2021 where they will be resuming this conversation. Register at https://www.dlapipertechsummit.com/european/?utm_source=soundcloud&utm_medium=social&utm_campaign=tech-summit&utm_term=europe&utm_content=tech-summit
  continue reading

57 episodes